1. Home
  2. CFFI vs ADCT Comparison

CFFI vs ADCT Comparison

Compare CFFI & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CFFI
  • ADCT
  • Stock Information
  • Founded
  • CFFI 1927
  • ADCT 2011
  • Country
  • CFFI United States
  • ADCT Switzerland
  • Employees
  • CFFI N/A
  • ADCT N/A
  • Industry
  • CFFI Major Banks
  • ADCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CFFI Finance
  • ADCT Health Care
  • Exchange
  • CFFI Nasdaq
  • ADCT Nasdaq
  • Market Cap
  • CFFI 219.5M
  • ADCT 241.0M
  • IPO Year
  • CFFI 1998
  • ADCT 2020
  • Fundamental
  • Price
  • CFFI $66.54
  • ADCT $3.23
  • Analyst Decision
  • CFFI
  • ADCT Strong Buy
  • Analyst Count
  • CFFI 0
  • ADCT 5
  • Target Price
  • CFFI N/A
  • ADCT $7.75
  • AVG Volume (30 Days)
  • CFFI 5.7K
  • ADCT 694.8K
  • Earning Date
  • CFFI 07-23-2025
  • ADCT 05-14-2025
  • Dividend Yield
  • CFFI 2.77%
  • ADCT N/A
  • EPS Growth
  • CFFI 10.01
  • ADCT N/A
  • EPS
  • CFFI 6.68
  • ADCT N/A
  • Revenue
  • CFFI $116,421,000.00
  • ADCT $75,817,000.00
  • Revenue This Year
  • CFFI N/A
  • ADCT $9.19
  • Revenue Next Year
  • CFFI N/A
  • ADCT $16.27
  • P/E Ratio
  • CFFI $9.97
  • ADCT N/A
  • Revenue Growth
  • CFFI 0.67
  • ADCT 10.49
  • 52 Week Low
  • CFFI $41.48
  • ADCT $1.05
  • 52 Week High
  • CFFI $89.90
  • ADCT $4.13
  • Technical
  • Relative Strength Index (RSI)
  • CFFI 51.28
  • ADCT 75.65
  • Support Level
  • CFFI $64.36
  • ADCT $1.83
  • Resistance Level
  • CFFI $68.20
  • ADCT $2.35
  • Average True Range (ATR)
  • CFFI 1.22
  • ADCT 0.31
  • MACD
  • CFFI -0.08
  • ADCT 0.12
  • Stochastic Oscillator
  • CFFI 38.72
  • ADCT 93.03

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: